David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
United Parks & Resorts
PRKS
$1.94B
| $3.62M | ﹤0.01% |
79,574
-44,158
| -36% | -$2.2M |
|
2302
Anika Therapeutics
ANIK
$284M
| $3.62M | ﹤0.01% |
152,028
-40,732
| -21% | -$937K |
|
2303
SiriusPoint
SPNT
$2.79B
| $3.62M | ﹤0.01% |
730,803
+173,656
| +31% | +$807K |
|
|
TRQ
2304
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $3.61M | ﹤0.01% |
+122,200
| New | +$3.33M |
|
2305
CALL
Darling Ingredients
DAR
$9.67B
| $3.6M | ﹤0.01% |
+54,500
| New | +$3.8M |
|
|
GSQB
2306
DELISTED
G Squared Ascend II Inc.
GSQB
| $3.6M | ﹤0.01% |
363,407
+23
| +0% | +$227 |
|
2307
Metropolitan Bank Holding Corp
MCB
$1.13B
| $3.6M | ﹤0.01% |
56,000
+4,673
| +9% | +$331K |
|
2308
Coca-Cola Consolidated
COKE
$13.1B
| $3.58M | ﹤0.01% |
87,020
+37,590
| +76% | +$1.85M |
|
2309
CALL
Reliance Steel & Aluminium
RS
$19.9B
| $3.58M | ﹤0.01% |
20,500
| – | – |
|
2310
CALL
Robinhood
HOOD
$99.7B
| $3.56M | ﹤0.01% |
352,500
-47,600
| -12% | -$458K |
|
2311
CALL
KKR & Co
KKR
$98.6B
| $3.56M | ﹤0.01% |
+82,800
| New | +$4.18M |
|
2312
Kearny Financial
KRNY
$645M
| $3.55M | ﹤0.01% |
334,661
-48,987
| -13% | -$563K |
|
|
TRTN
2313
CALL
DELISTED
Triton International Limited
TRTN
| $3.55M | ﹤0.01% |
64,900
+43,300
| +200% | +$2.59M |
|
2314
Bunge Global
BG
$21.4B
| $3.54M | ﹤0.01% |
42,845
+15,870
| +59% | +$1.48M |
|
2315
PUT
Edwards Lifesciences
EW
$52.3B
| $3.54M | ﹤0.01% |
+42,800
| New | +$4.12M |
|
2316
Veeva Systems
VEEV
$46.4B
| $3.53M | ﹤0.01% |
21,425
-143,423
| -87% | -$28.7M |
|
2317
CALL
Vipshop
VIPS
$6.38B
| $3.53M | ﹤0.01% |
420,000
| – | – |
|
2318
CACI
CACI
$13.9B
| $3.52M | ﹤0.01% |
13,469
-5,213
| -28% | -$1.47M |
|
2319
HealthStream
HSTM
$847M
| $3.5M | ﹤0.01% |
164,804
-14,144
| -8% | -$322K |
|
|
EDNC
2320
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
| $3.5M | ﹤0.01% |
349,053
| – | – |
|
2321
Evercore
EVR
$11.2B
| $3.49M | ﹤0.01% |
42,453
+31,179
| +277% | +$2.95M |
|
2322
PUT
HP
HPQ
$26.8B
| $3.49M | ﹤0.01% |
140,000
-100
| -0.1% | -$3.07K |
|
|
2323
CALL
HP
HPQ
$26.8B
| $3.48M | ﹤0.01% |
139,800
+44,900
| +47% | +$1.38M |
|
2324
CALL
Mohawk Industries
MHK
$8.88B
| $3.48M | ﹤0.01% |
38,200
-3,300
| -8% | -$383K |
|
2325
Korn Ferry
KFY
$4.36B
| $3.48M | ﹤0.01% |
74,102
-14,041
| -16% | -$829K |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.